本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

5.86
-0.5000-7.86%
盘后5.900.0400+0.68%19:59 EDT
成交量:7,019.12万
成交额:4.20亿
市值:25.44亿
市盈率:-3.25
高:6.25
开:6.15
低:5.81
收:6.36
52周最高:12.36
52周最低:3.79
股本:4.34亿
流通股本:4.15亿
量比:0.56
换手率:16.91%
股息:- -
股息率:- -
每股收益(TTM):-1.8042
每股收益(LYR):-1.6909
净资产收益率:-86.34%
总资产收益率:-39.08%
市净率:2.77
市盈率(LYR):-3.47

数据加载中...

2024/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/02

重要事件披露

Form 8-K - Current report
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]